康弘藥業:康弘生物康柏西普眼用注射液收到《藥物臨床試驗批准通知書》 1970-01-01T00:00:00-05:00January 1st, 1970| share this article!康弘藥業全資子公司成都康弘生物科技有限公司于近日收到國家藥品監督管理局簽發的關于康柏西普眼用注射液的《藥物臨床試驗批准通知書》(通知書編號:2021LP00814),同意開展臨床試驗。 Read More share this article! Related Posts China tightens IPO rules for STAR Market hopefuls May 4th, 2024 Airbnb looking to fly high on Asia-Pacific’s young travellers May 4th, 2024 China’s Zeekr seeks over $5b valuation in US IPO May 4th, 2024 Tech platforms make pitch for ad dollars as politics continues to roil TikTok May 4th, 2024